focus -WSS

focus

author：leisure time 2025-10-01 05:38:24 - browse：1

King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT — Pat Greenhouse/Globe Staff

MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Can we make enough H5N1 bird flu vaccine if there's a pandemic?

WSS

NIH study of ME/CFS points to clear biological hallmarks

PBM reform efforts get punted in Congress

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

NIH study of ME/CFS points to clear biological hallmarks

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Wearables generate powerful data but its not useful to doctors, yet

focus

focus

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

New documents shed light on MD Anderson Cancer Institute feud

23andMe had bad news about my health. I wish a person had delivered it

It's time to retire 'poor historian' from clinicians' vocabularies

Jerome Adams on the need for new antivirals for Covid

Alabama IVF ruling threatens families facing fatal genetic disease

Jerome Adams on the need for new antivirals for Covid

Helping hospitals and community health centers plan for resilience

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

focus

Arc Institute generative AI designs new CRISPR systems

Arc Institute generative AI designs new CRISPR systems

Cytokinetics CEO stresses company can launch heart drug on its own

Data integrity in scientific journals requires "effort" by publishers, institutions

Venture capitalist Bob Kocher on the state of digital health

Readout LOUD podcast: Humira legacy, AbbVie CEO's retirement

focus

explore

focus

hotspot